SPECIALIZING IN DUE DILIGENCE, PRODUCT DEVELOPMENT, INVESTOR RELATIONS, AND COMMERCIALIZATION OF THERAPIES*
*PHARMACEUTICALS, BIOLOGICS, MEDICAL DEVICES, AND DIAGNOSTICS
Business Decisions Ensuring Company and Product Success
Our strategic insights in the areas of due diligence, product development, investor relations, and commercialization empower our clients to make actionable business decisions to ensure company and product success in the rapidly changing medical marketplace.
Ensure our clients in established and emerging pharmaceutical, biotech, and medical device companies, and biotech investors make informed business decisions.
Conduct in-depth due diligence facilitated by market research and competitive intelligence, and validate findings with feedback from key stakeholder interviews.
Navigate health care product journeys by developing clinical trials with appropriate end points, facilitating regulatory decision making, and traversing reimbursement and payer barriers.
Deliver forward looking marketing and medical guidance on emerging and approved therapies for many different diseases, including many types of cancers and orphan diseases.
“Premier Endpoint has been a fantastic source for supplementing our own knowledge regarding new scientific data. We have primarily utilized their services consisting of finding and interviewing key opinion leaders (KOLs) across the US and EU markets. The feedback provided by these KOLs has allowed us to contextualize how new therapies will be used in the real world, how new data will impact clinical practice, and any hurdles that may arise going forward.
I would highly recommend Premier Endpoint to any medical oriented organization seeking to complement or further understand issues spanning the entire drug development process. Klara and Stephen have been transparent and very communicative throughout projects, all while exhibiting the highest degree of professionalism. They both have been a true pleasure to work with, and we greatly appreciate their services.“
- Senior Analyst, Private Consulting Firm